We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-1.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$1.17B
AUM Growth
+$393M
Cap. Flow
+$459M
Cap. Flow %
39.32%
Top 10 Hldgs %
24.34%
Holding
4,355
New
842
Increased
1,505
Reduced
871
Closed
1,089

Sector Composition

Rank Sector Weight
1 Financials 6.98%
2 Industrials 6.05%
3 Consumer Discretionary 5.52%
4 Technology 5.03%
5 Healthcare 4.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QADA
2526
DELISTED
QAD Inc.
QADA
$9K ﹤0.01%
227
-192
-46% -$8.2K
VVUS
2527
DELISTED
Vivus Inc
VVUS
$9K ﹤0.01%
2,635
+1,972
+297% +$9.12K
ALDX icon
2528
Aldeyra Therapeutics
ALDX
$91.1M
$8K ﹤0.01%
1,053
+1,029
+4,288% +$7.81K
ASYS icon
2529
Amtech Systems
ASYS
$282M
$8K ﹤0.01%
1,157
+912
+372% +$8.21K
BELFA icon
2530
Bel Fuse Inc Class A
BELFA
$3.45B
$8K ﹤0.01%
471
+304
+182% +$5.56K
BP icon
2531
BP
BP
$110B
$8K ﹤0.01%
215
-19,004
-99% -$716K
BTG icon
2532
B2Gold
BTG
$6.78B
$8K ﹤0.01%
3,073
-40,760
-93% -$120K
BZH icon
2533
Beazer Homes USA
BZH
$873M
$8K ﹤0.01%
500
-2,496
-83% -$44.2K
CPRX
2534
DELISTED
Catalyst Pharmaceutical
CPRX
$8K ﹤0.01%
3,198
-9,479
-75% -$31.5K
CSTE icon
2535
Caesarstone
CSTE
$116M
$8K ﹤0.01%
404
-761
-65% -$16.4K
CTSO icon
2536
Cytosorbents Corp
CTSO
$24.5M
$8K ﹤0.01%
1,072
+294
+38% +$2.22K
CVGW
2537
DELISTED
Calavo Growers
CVGW
$8K ﹤0.01%
87
-110
-56% -$9.63K
CYTK icon
2538
Cytokinetics
CYTK
$10.2B
$8K ﹤0.01%
1,073
-3,955
-79% -$33.9K
DLHC icon
2539
DLH Holdings
DLHC
$68.4M
$8K ﹤0.01%
1,415
-244
-15% -$1.45K
ENZL icon
2540
iShares MSCI New Zealand ETF
ENZL
$83M
$8K ﹤0.01%
173
-100
-37% -$4.86K
ESPR
2541
DELISTED
Esperion Therapeutics
ESPR
$8K ﹤0.01%
112
-194
-63% -$14.2K
ESQ icon
2542
Esquire Financial Holdings
ESQ
$1.57B
$8K ﹤0.01%
331
+57
+21% +$1.26K
ET icon
2543
Energy Transfer Partners
ET
$72.4B
$8K ﹤0.01%
560
+262
+88% +$4.36K
FOXF icon
2544
Fox Factory Holding Corp
FOXF
$887M
$8K ﹤0.01%
226
+167
+283% +$6.34K
GPRE icon
2545
Green Plains
GPRE
$1.08B
$8K ﹤0.01%
478
-319
-40% -$5.74K
ICL icon
2546
ICL Group
ICL
$7.19B
$8K ﹤0.01%
1,963
+680
+53% +$2.91K
ILF icon
2547
iShares Latin America 40 ETF
ILF
$3.69B
$8K ﹤0.01%
+204
New +$7.64K
INVA icon
2548
Innoviva
INVA
$1.53B
$8K ﹤0.01%
+501
New +$7.73K
KE
2549
Kimball Electronics
KE
$624M
$8K ﹤0.01%
509
-145
-22% -$2.61K
KGC icon
2550
Kinross Gold
KGC
$32.3B
$8K ﹤0.01%
2,140
-131,834
-98% -$526K

Similar funds

Tower Research Capital (TRC)'s Q1 2018 Portfolio in Review

As of Q1 2018, Tower Research Capital (TRC) held 4,355 positions worth $1.17B, up 51% from $775M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Tower Research Capital (TRC) deployed $459M of net new capital in Q1 2018, opening 842 new positions and adding to 1,505 existing holdings. Its largest new stake was iShares MSCI EAFE ETF: 717,758 shares worth $50M.

By sector, the portfolio is most concentrated in Financials at 7% of assets, down from 11% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $21M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2018 buy was iShares MSCI EAFE ETF: 717,758 shares worth $50M.
  • Tower Research Capital (TRC) added most to iShares MSCI Emerging Markets ETF in Q1 2018, an estimated $69.7M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $21M.
  • Tower Research Capital (TRC) fully exited Berkshire Hathaway Class B in Q1 2018, selling an estimated $7.94M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 24% of its $1.17B portfolio in Q1 2018.
  • Tower Research Capital (TRC) opened 842 new positions and closed 1,089 in Q1 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 51% quarter-over-quarter to $1.17B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2018, filed 15 May 2018.